Company Filing History:
1 out of 8,375 
1 out of 444 
Years Active: 2022
Title: Innovations in Lung Cancer Treatment by Chengcheng Jin
Introduction
Chengcheng Jin is an innovative inventor based in Cambridge, MA, who has made significant contributions to the field of lung cancer treatment. His research focuses on the relationship between lung microbiota and immune responses, providing new insights into potential therapeutic approaches.
Latest Patents
Chengcheng Jin holds a patent titled "Methods and compositions targeting lung microbiota and its responding immune pathways for lung cancer treatment." This patent addresses the dysregulation of local microbiota associated with lung tumor growth. It highlights how commensal bacteria can provoke chronic inflammation and exacerbate lung cancer through tumor-infiltrating immune cells. The patent discloses methods for targeting lung microbiota and its immune pathways by administering therapeutics, such as antibiotics, to reduce bacterial load and inhibit immune responses.
Career Highlights
Chengcheng Jin has worked at prestigious institutions, including the Massachusetts Institute of Technology and the Broad Institute, Inc. His work has been pivotal in advancing our understanding of lung cancer and its treatment.
Collaborations
Chengcheng has collaborated with notable colleagues, including Georgia Lagoudas and Paul Blainey, contributing to a rich environment of innovation and research.
Conclusion
Chengcheng Jin's work exemplifies the intersection of microbiology and oncology, offering promising avenues for lung cancer treatment through targeted therapies. His contributions are vital in the ongoing fight against this challenging disease.